clinicaltrialsarena1h
Minister for Science champions partnerships with private clinical sector in UK
Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.
clinicaltrialsarena1h
Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents
Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...
clinicaltrialsarena2h
Minghui Pharmaceutical’s MHB039A shows promise in Phase I trial for solid tumours
Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with solid ...
clinicaltrialsarena22h
Lord O’Shaughnessy expresses optimism for clinical trials in the UK
The former health minister predicted a bright future for UK trials and outlined steps to ensure clinical research thrives.
clinicaltrialsarena19h
Customer-centricity takes spotlight during clinical transformation
Alcon’s session at the 2024 Veeva MedTech Summit in Amsterdam. Image Credit: Ross Law / GlobalData. Alcon decided to take a ...
clinicaltrialsarena8h
Ionis announces design for Phase III trial of Angelman syndrome therapy
Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.
clinicaltrialsarena19h
Castle boasts melanoma test’s capacity to reduce unnecessary testing
Castle’s DecisionDx-Melanoma test is one of the company’s most in-demand products. Image credit: Pressmaster / Shutterstock. Castle Biosciences has released data from a multi-centre DECIDE study ...